CELEX: 62018TA0740
Language: en
Date: 2022-02-09 00:00:00
Title: Case T-740/18: Judgment of the General Court of 9 February 2022 — Taminco and Arysta LifeScience Great Britain v Commission (Plant protection products — Active substance thiram — Non-renewal of approval — Regulation No 1107/2009 and Implementing Regulation No 844/2012 — Rights of the defence — Procedural irregularity — Manifest error of assessment — Competence of EFSA — Proportionality — Precautionary principle — Equal treatment)

21.3.2022   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 128/16
            
         
      Judgment of the General Court of 9 February 2022 — Taminco and Arysta LifeScience Great Britain v Commission
      (Case T-740/18) (1)
      
      (Plant protection products - Active substance thiram - Non-renewal of approval - Regulation No 1107/2009 and Implementing Regulation No 844/2012 - Rights of the defence - Procedural irregularity - Manifest error of assessment - Competence of EFSA - Proportionality - Precautionary principle - Equal treatment)
      (2022/C 128/21)
      Language of the case: English
      
         Parties
      
      
         Applicants: Taminco BVBA (Ghent, Belgium), Arysta LifeScience Great Britain Ltd (Edinburgh, United Kingdom) (represented by: C. Mereu and M. Grunchard, lawyers)
      
         Defendant: European Commission (represented by: G. Koleva, acting as Agent)
      
         Re:
      
      APPLICATION under Article 263 TFEU for annulment of Commission Implementing Regulation (EU) 2018/1500 of 9 October 2018 concerning the non-renewal of approval of the active substance thiram, and prohibiting the use and sale of seeds treated with plant protection products containing thiram, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ 2018 L 254, p. 1).
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Taminco BVBA and Arysta LifeScience Great Britain Ltd to bear their own costs and those incurred by the European Commission in the context of the present action;
               
            
                  3.
               
               
                  Orders Taminco to bear its own costs and those incurred by the Commission in the context of the proceedings for interim measures.
               
            
         (1)  OJ C 72, 25.2.2019.